Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, ...

PROCEPT BioRobotics (NASDAQ:PRCT) used its 2026 Analyst Day to outline what management characterized as a large, underpenetrated opportunity in benign prostatic hyperplasia (BPH), a developing ...

Detailed price information for Procept Biorobotics Corp (PRCT-Q) from The Globe and Mail including charting and trades.

Men from across Surrey are set to benefit from a major investment in leading medical technology at Nuffield Health Woking Hospital, as the hospital launches Aquablation therapy for patients suffering ...

PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the 'Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported ...

HSHS St. Elizabeth’s Hospital is proud to announce the 100th Aquablation therapy procedure, marking a significant milestone ...

As the prostate gland enlarges in men, which often happens in men above 50 years, urinary symptoms creep into men's most ...

Therapeutic Dr Allen’s Devices are designed to treat different chronic health conditions, including kidney stones (known as ...

A MODIFIED form of water vapour thermal therapy may offer a safe and effective option for men with large-volume benign prostatic hyperplasia (BPH), according to new prospective research. The study ...

Bipolar enucleation significantly reduced IPSS in men with large prostates and obstructed bladder necks, but the procedure led to a high rate of retrograde ejaculation. Bipolar enucleation of the ...

Credit: Getty Images This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men. Familial clustering studies ...